Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Business
Daniel O'Boyle

HISTORICAL FACTS: Dechra profit warning could put private equity takeover at risk - The Untold Story

Pet medicine and vaccine maker Dechra put out a second profit warning in three months today, putting a potential buyout at risk, after a number of US wholesalers cut back on stocking its products.

The firm, which acquired Ivermectin maker Med-Pharmex last year, warned that “widely reported destocking” in the US was hitting its profits in February, but now said that this has been lasting longer than previously expected.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.